glycerylphosphorylcholine has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamska-Patruno, E; Barbas, C; Ciborowski, M; Godzien, J; Kalaska, B; Kretowski, A; Siroka, J | 1 |
| Bolo, NR; Fried, PJ; Pascual-Leone, A | 1 |
| Chambers, ST; Elmslie, JL; Florkowski, CM; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Slow, S | 1 |
| Chambers, ST; Elmslie, JL; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Parry-Strong, A; Slow, S | 1 |
| Crawford, M; Ghebremeskel, K; Lowy, C; Min, Y; Offley-Shore, B; Thomas, B | 1 |
2 trial(s) available for glycerylphosphorylcholine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.
Topics: Aged; Betaine; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcholine; Humans; Male; Methylamines; Middle Aged; Overweight; Sarcosine; Taurine; Time Factors | 2015 |
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
Topics: Adult; Aged; Betaine; Bezafibrate; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcholine; Homocysteine; Humans; Hypolipidemic Agents; Inositol; Male; Middle Aged; Sarcosine; Taurine; Young Adult | 2014 |
3 other study(ies) available for glycerylphosphorylcholine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: Their annotation and biological meaning.
Topics: Adult; Chromatography, Liquid; Diabetes Mellitus, Type 2; Glycerylphosphorylcholine; Humans; Metabolome; Metabolomics; Middle Aged; Oxidation-Reduction; Tandem Mass Spectrometry | 2019 |
Diabetes and the link between neuroplasticity and glutamate in the aging human motor cortex.
Topics: Aged; Aged, 80 and over; Aging; Aspartic Acid; Creatine; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; Glutamic Acid; Glutamine; Glutathione; Glycerylphosphorylcholine; Humans; Inositol; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Neuronal Plasticity; Phosphocreatine; Phosphorylcholine; Prediabetic State; Theta Rhythm; Transcranial Magnetic Stimulation | 2019 |
Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance.
Topics: Adult; Arachidonic Acid; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Erythrocyte Membrane; Fatty Acids, Essential; Female; Fetal Blood; Glycerylphosphorylcholine; Humans; Insulin Resistance; Maternal-Fetal Exchange; Phosphatidylethanolamines; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Triglycerides | 2005 |